Group 1 - The inclusion of the HPV vaccine in the national immunization program is a significant step towards reducing the burden of cervical cancer in China and promoting public health [4][5] - The target population for the free vaccination program is girls aged 13 years and older, who will receive two doses of the bivalent HPV vaccine, with a six-month interval between doses [4] - In 2022, approximately 151,000 new cases of cervical cancer were reported in China, with around 56,000 deaths, highlighting the urgency of preventive measures [4] Group 2 - The domestic production capacity for the bivalent HPV vaccine is 55 million doses annually, sufficient to meet market demand, and both manufacturers have received pre-certification from the World Health Organization [5] - The initiative to include the HPV vaccine in the national immunization program represents a new phase in China's immunization efforts, aiming to enhance health equity and accessibility [5] - The collaboration among various departments is essential to ensure the smooth implementation of the vaccination policy, which aims to protect more girls from cervical cancer [5]
11月10日起 满13周岁女孩免费接种HPV疫苗！
Zhong Guo Ji Jin Bao·2025-10-30 15:12